Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is ...

Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug ...

But three of those FDA employees told CNN that Elsa just makes up nonexistent studies, something commonly referred to in AI ...

In recent years, Artificial Intelligence (AI) has made significant strides across various sectors, providing innovative solutions and enhancing efficiency. However, ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

The FDA's 'Elsa' AI, intended to speed up drug approvals, is reportedly fabricating studies, part of a wider trend of unreliable AI in high-stakes roles.

The Food and Drug Administration's new AI tool, Elsa, is reportedly generating false studies, raising concerns about the ...

FDA officials say the assistant is flawed, just as the Trump administration stresses AI adoption in healthcare.

“If the question is, can AI replace a human reviewer, I would say absolutely not,” said Jason Conaty, counsel in the Los Angeles office of Hogan Lovells who specializes in drug regulatory affairs.

For decades, Alzheimer’s disease has resisted nearly every significant pharmaceutical intervention. Despite billions invested ...

The U.S. Food and Drug Administration (FDA) has introduced “Elsa,” a generative AI tool designed to enhance the efficiency of its regulatory operations.

AI is helping close the translational gap. During the early stages of drug development, AI algorithms are helping scientists whittle down thousands of potential drugs to the most promising candidates.